is a listed company, headquartered in Belgium, and employs 1800 people across the globe mobilizing their skills and passion to Protect, Enhance and Save lives. We develop, manufactures and supports innovative equipment and software solutions for diagnostic, cancer treatment, and industrial applications.



Innovating for life since more than 30 years, IBA has open new ways to diagnose and fight cancer and become the worldwide technology leader in the field of Proton Therapy, which is today the most advanced technologies treatment against cancer. Our core particle accelerators knowledge is unparalleled, with 100,000 patients treated on our proton therapy solutions and over 550 accelerators in operation globally.







IBA ‘s world class expertise lies in the development of: